PATENT CLAIM ANALYSIS

Application Number: 16078403
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "299000"]

Abstract:
The invention provides methods for modulating the activity of farnesoid X receptors (FXRs) using specific FXR agonists, in particular for treating or preventing liver and gastrointestinal diseases.

Claim (Index 4):
The method according to  claim 1 , wherein the dose is a daily dose.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 96.0
- Lexical Diversity: 1.03333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15263033', '16030141', '13402819', '15598734', '14743295']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7696270099388852
- 35 USC 102 Novelty (BERT): 0.4871422998375203
- Combined Prediction Score: 0.7413785389287488
- Mean Citation Score: 218.937124
- Max Citation Score: 227.21574
- Similarity Product: 181.7431519799388

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test